Mountain View, CA, United States of America

Tom Schall


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Mountain View, CA (US) (2019 - 2021)
  • San Carlos, CA (US) (2024)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Tom Schall in Pancreatic Cancer Treatment

Introduction

Tom Schall is a notable inventor based in Mountain View, CA (US), recognized for his significant contributions to the field of cancer treatment. With a total of six patents to his name, Schall has focused his research on innovative methods to combat pancreatic cancer, a disease known for its challenging prognosis.

Latest Patents

Among his latest patents, Schall has developed methods of treating pancreatic cancer. These patents describe techniques aimed at limiting the over-expression of oncogenes, activating tumor suppressor genes, and regulating signaling proteins in patients. The methods involve administering specific compounds and pharmaceutical combinations that have shown promise in clinical applications.

Career Highlights

Schall's career is marked by his role at Chemocentryx, Inc., where he has been instrumental in advancing research and development in cancer therapies. His work has not only contributed to the scientific community but has also provided hope for patients battling pancreatic cancer.

Collaborations

Throughout his career, Schall has collaborated with esteemed colleagues such as Petrus Bekker and Shichang Miao. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of effective treatments.

Conclusion

Tom Schall's innovative work in the treatment of pancreatic cancer exemplifies the impact of dedicated research and collaboration in the medical field. His contributions continue to pave the way for advancements in cancer therapies, offering hope to many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…